Health

ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

MedPage Today) — CHICAGO — First-line trastuzumab deruxtecan (T-DXd) combined with pertuzumab (Perjeta) improved progression-free survival (PFS) in HER2-positive locally advanced or metastatic breast cancer, according to the DESTINY-Breast09…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app